Transaction · 0001715429-26-000007

Ware J. Anthony

Ware J. Anthony, DIR, reported an open-market or private sale at First Tracks Biotherapeutics, Inc. involving 39265.000000 shares for an estimated $1758145.35. Reported holdings after the transaction were 15660.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SDIR
TRAXFirst Tracks Biotherapeutics, Inc.
Filing timeSep 04
Trade dateSep 02, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$40.46
Pre-filing
1mo ago +14.1%1w ago +9.2%1d ago +1.8%
Returns since
7d +0.0%30d +0.0%90d +0.0%180d +0.0%1y +0.0%

TRAX price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
TRAX since 2026-09-04Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001715429-26-000007
Common Stock
Transaction date
Sep 02, 2026
Filed Sep 04, 2026, 08:25 PM · 2d delay
Shares
39.2k sh
$4.47k per share
Estimated value
-$175M
Computed from shares × price
Holdings after
15.6k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Holdings Reduction Large Sale
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.62 to $45.28 per share, inclusive. The Reporting Person undertake…

  2. F2

    The stock option is fully vested.

  3. F3

    In addition to the shares the Reporting Person owns reported in Table I, the Reporting Person also holds additional options to purchase up to an aggregate of 99,320 shares of common stock and 6,500 re…

Original filing · 0001715429-26-000007
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

TRAX